Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLAWED: Continuous Lidocaine Wound Infusion in Head and Neck Cancer Surgery
NCT06201039Not yet recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Mar 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of lidocaine in head and neck cancer (HNC) (2 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: Quality of Recovery-15 at 24 hours. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT06201039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06201039.